A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

NCT01587703 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Midline

Interventions

DRUG: GSK525762

Sponsor

GlaxoSmithKline